关于为静脉曲张与静脉疾病治疗制定全国覆盖决定的提案
本文指出静脉曲张和慢性静脉疾病在美國常见且影响生活质量,已有多种有效干预措施,但常受CMS和商业保险限制。CMS通过10个辖区的承包商执行Medicare政策,缺乏全国统一覆盖政策,各地政策不一且非循证,导致同一Medicare人群因居住地不同而覆盖不公平。作者因此提议制定全国覆盖决定政策。
要点
- 静脉曲张与慢性静脉疾病常见且影响生活质量,已有有效干预措施。
- CMS无全国统一覆盖政策,10个辖区承包商各自制定政策且差异大。
- 各地政策非循证,同一Medicare人群因居住地不同而覆盖不公平。
核心结论
- 应制定全国覆盖决定政策以统一静脉曲张治疗的Medicare覆盖。
研究设计与样本
- 本文为政策提案,未报告系统检索或样本量。
主要发现
- CMS在美國10个辖区由承包商执行Medicare政策,无全国统一静脉曲张治疗覆盖政策。
- 各地承包商政策不一且非循证,导致同一Medicare人群因居住地不同而覆盖不公平。
临床怎么用
- 血管外科医生可参考本提案推动全国统一覆盖政策,减少地区差异。
局限性
- 本文为提案,未提供原始研究数据或系统评价。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Varicose veins and chronic venous disease are common problems in the United States. Persons with these conditions often have an adversely affected quality of life. There are a number of proven interventions to treat varicose veins and to improve patients' life quality, but these interventions are often restricted by the Centers for Medicare and Medicaid Services and private third-party payers. The Centers for Medicare and Medicaid Services have private contractors that administer Medicare policies in 10 jurisdictions across the United States. There is no national policy or coverage for the treatment of varicose veins; rather, there are multiple, disparate regional policies written by the contractors that cover the same Medicare beneficiary population. These disparate policies are not evidence based and provide unfair coverage of the same disease to the Medicare population, depending on where they live. Our proposal is for a national coverage determination policy for the treatment of varicose veins.
引用
- Welch HJ, Kabnick L, Vasquez MA, et al. Proposal for a national coverage determination for the treatment of varicose veins and venous disease due to disparate Centers for Medicare and Medicaid Services local coverage determination policies. J Vasc Surg Venous Lymphat Disord. 2017. PMID: 28411715. doi:10.1016/j.jvsv.2017.01.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。